JP2006521121A5 - - Google Patents

Download PDF

Info

Publication number
JP2006521121A5
JP2006521121A5 JP2006503990A JP2006503990A JP2006521121A5 JP 2006521121 A5 JP2006521121 A5 JP 2006521121A5 JP 2006503990 A JP2006503990 A JP 2006503990A JP 2006503990 A JP2006503990 A JP 2006503990A JP 2006521121 A5 JP2006521121 A5 JP 2006521121A5
Authority
JP
Japan
Prior art keywords
agent
population
enriched population
mpc
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006503990A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006521121A (ja
JP5721302B2 (ja
Filing date
Publication date
Priority claimed from AU2003901668A external-priority patent/AU2003901668A0/en
Application filed filed Critical
Publication of JP2006521121A publication Critical patent/JP2006521121A/ja
Publication of JP2006521121A5 publication Critical patent/JP2006521121A5/ja
Application granted granted Critical
Publication of JP5721302B2 publication Critical patent/JP5721302B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006503990A 2003-03-28 2004-03-29 血管周囲の間葉系前駆細胞に誘導される血管形成 Expired - Lifetime JP5721302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2003901668A AU2003901668A0 (en) 2003-03-28 2003-03-28 Non-haemopoietic precursor cells
AU2003901668 2003-03-28
PCT/AU2004/000417 WO2004084921A1 (en) 2003-03-28 2004-03-29 Perivascular mesenchymal precursor cell induced blood vessel formation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013169111A Division JP6096082B2 (ja) 2003-03-28 2013-08-16 血管周囲の間葉系前駆細胞に誘導される血管形成

Publications (3)

Publication Number Publication Date
JP2006521121A JP2006521121A (ja) 2006-09-21
JP2006521121A5 true JP2006521121A5 (cg-RX-API-DMAC7.html) 2012-09-27
JP5721302B2 JP5721302B2 (ja) 2015-05-20

Family

ID=31500707

Family Applications (10)

Application Number Title Priority Date Filing Date
JP2006503989A Pending JP2006521096A (ja) 2003-03-28 2004-03-29 脈管周囲の間葉系前駆細胞
JP2006503990A Expired - Lifetime JP5721302B2 (ja) 2003-03-28 2004-03-29 血管周囲の間葉系前駆細胞に誘導される血管形成
JP2010274732A Expired - Lifetime JP6043469B2 (ja) 2003-03-28 2010-12-09 脈管周囲の間葉系前駆細胞
JP2013122605A Expired - Lifetime JP6188435B2 (ja) 2003-03-28 2013-06-11 脈管周囲の間葉系前駆細胞
JP2013169111A Expired - Lifetime JP6096082B2 (ja) 2003-03-28 2013-08-16 血管周囲の間葉系前駆細胞に誘導される血管形成
JP2015046026A Expired - Lifetime JP6096232B2 (ja) 2003-03-28 2015-03-09 血管周囲の間葉系前駆細胞に誘導される血管形成
JP2015112336A Expired - Lifetime JP6257559B2 (ja) 2003-03-28 2015-06-02 脈管周囲の間葉系前駆細胞
JP2016204162A Pending JP2017014285A (ja) 2003-03-28 2016-10-18 血管周囲の間葉系前駆細胞に誘導される血管形成
JP2017110753A Pending JP2017148076A (ja) 2003-03-28 2017-06-05 脈管周囲の間葉系前駆細胞
JP2018172420A Pending JP2019006814A (ja) 2003-03-28 2018-09-14 血管周囲の間葉系前駆細胞に誘導される血管形成

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006503989A Pending JP2006521096A (ja) 2003-03-28 2004-03-29 脈管周囲の間葉系前駆細胞

Family Applications After (8)

Application Number Title Priority Date Filing Date
JP2010274732A Expired - Lifetime JP6043469B2 (ja) 2003-03-28 2010-12-09 脈管周囲の間葉系前駆細胞
JP2013122605A Expired - Lifetime JP6188435B2 (ja) 2003-03-28 2013-06-11 脈管周囲の間葉系前駆細胞
JP2013169111A Expired - Lifetime JP6096082B2 (ja) 2003-03-28 2013-08-16 血管周囲の間葉系前駆細胞に誘導される血管形成
JP2015046026A Expired - Lifetime JP6096232B2 (ja) 2003-03-28 2015-03-09 血管周囲の間葉系前駆細胞に誘導される血管形成
JP2015112336A Expired - Lifetime JP6257559B2 (ja) 2003-03-28 2015-06-02 脈管周囲の間葉系前駆細胞
JP2016204162A Pending JP2017014285A (ja) 2003-03-28 2016-10-18 血管周囲の間葉系前駆細胞に誘導される血管形成
JP2017110753A Pending JP2017148076A (ja) 2003-03-28 2017-06-05 脈管周囲の間葉系前駆細胞
JP2018172420A Pending JP2019006814A (ja) 2003-03-28 2018-09-14 血管周囲の間葉系前駆細胞に誘導される血管形成

Country Status (14)

Country Link
US (6) US9169466B2 (cg-RX-API-DMAC7.html)
EP (4) EP2380969B1 (cg-RX-API-DMAC7.html)
JP (10) JP2006521096A (cg-RX-API-DMAC7.html)
CN (4) CN1822846B (cg-RX-API-DMAC7.html)
AU (7) AU2003901668A0 (cg-RX-API-DMAC7.html)
CA (4) CA2816489C (cg-RX-API-DMAC7.html)
DK (1) DK1613335T3 (cg-RX-API-DMAC7.html)
ES (3) ES2784378T3 (cg-RX-API-DMAC7.html)
FR (1) FR20C1036I2 (cg-RX-API-DMAC7.html)
NL (1) NL301059I2 (cg-RX-API-DMAC7.html)
PL (1) PL1613335T3 (cg-RX-API-DMAC7.html)
PT (1) PT1613335E (cg-RX-API-DMAC7.html)
SI (1) SI1613335T1 (cg-RX-API-DMAC7.html)
WO (2) WO2004084921A1 (cg-RX-API-DMAC7.html)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514074B2 (en) 1997-07-14 2009-04-07 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
US7670628B2 (en) * 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US20050158289A1 (en) * 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
US8062675B2 (en) 1999-07-07 2011-11-22 Angioblast Systems, Inc. Mesenchymal precursor cell
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
JP4790592B2 (ja) * 2003-02-11 2011-10-12 ダビース，ジヨン・イー ヒト臍帯のウォートンジェリーからの前駆細胞
CN101103101B (zh) * 2004-09-24 2012-10-10 成血管细胞系统公司 增强间充质前体细胞（mpc）的增生和/或存活的方法
TR201900968T4 (tr) * 2004-09-24 2019-02-21 Mesoblast Inc Multipotansiyel genleşmiş mezenkimal prekürsör hücre soyu (memp) ve bunların kullanımı.
US8287853B2 (en) 2005-02-11 2012-10-16 Agency For Science, Technology And Research Methods of culturing mesenchymal stem cells
US8178085B2 (en) 2005-02-11 2012-05-15 Agency For Science, Technology And Research Methods of proliferating stem cells
US8367405B2 (en) * 2005-04-12 2013-02-05 Mesoblast, Inc. Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
US20080213235A1 (en) * 2005-07-29 2008-09-04 University Of Virginia Patent Foundation Adipose Tissue Stem Cells, Perivascular Cells and Pericytes
EP1780265A1 (en) * 2005-10-25 2007-05-02 Stiftung CAESAR Differentiation of stem cells into chondrocytes
CN101479377A (zh) * 2005-12-22 2009-07-08 简·恩尼斯 来自冷冻的脐带组织的活细胞
BRPI0710339A2 (pt) 2006-05-05 2011-08-09 Jane Ennis método de modulação de uma reação imunólogica, método de redução e extrato
AU2007272313B2 (en) * 2006-07-12 2013-11-21 Mesoblast, Inc. Treatment of excessive neovascularization
FR2909559B1 (fr) * 2006-12-06 2012-09-07 Inst Vaisseaux Et Du Sang Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
WO2008077094A2 (en) * 2006-12-19 2008-06-26 Children's Medical Center Corporation Methods for promoting neovascularization
CA2679178A1 (en) * 2007-02-26 2008-09-04 Mount Sinai Hospital Compositions and methods for treating peripheral vascular diseases
CN103169731A (zh) 2007-08-06 2013-06-26 成血管细胞系统公司 用于体内生成、修复和/或维护结缔组织的方法
WO2009129616A1 (en) 2008-04-21 2009-10-29 Tissue Regeneration Therapeutics, Inc. Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents
KR20170104643A (ko) * 2008-06-25 2017-09-15 메소블라스트, 아이엔씨. 추간판의 치료 및/또는 재구성
WO2010005527A1 (en) 2008-06-30 2010-01-14 Angioblast Systems, Inc. Treatment of eye diseases and excessive neovascularization using a combined therapy
WO2010011185A1 (en) * 2008-07-21 2010-01-28 Agency For Science, Technology And Research Stem cells obtained through in vitro culture with heparan sulfate
NZ591292A (en) 2008-08-20 2012-10-26 Anthrogenesis Corp Improved cell composition and methods of making the same
MX2008014536A (es) * 2008-11-13 2009-01-16 Internac Para La Terapia Celul Compuesto de regeneracion celular.
CN104546912B (zh) 2008-11-20 2019-11-08 中胚有限公司 用于治疗胰功能异常的方法
WO2010105311A1 (en) 2009-03-20 2010-09-23 Angioblast Systems, Inc. Production of reprogrammed pluripotent cells
WO2011022070A2 (en) * 2009-08-20 2011-02-24 The Regents Of The University Of California Perivascular stem cell composition for bone
EP2491400B1 (en) 2009-10-21 2015-10-07 MyCartis N.V. Biomarker for diagnosis, prediction and/or prognosis of acute heart failure and uses thereof
WO2011106234A1 (en) 2010-02-25 2011-09-01 Provasculon, Inc. Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
KR101871472B1 (ko) 2010-07-02 2018-06-27 메소블라스트, 아이엔씨. 이식편대숙주 질환의 치료 방법
US9301976B2 (en) * 2010-08-19 2016-04-05 The Regents Of The University Of California Compositions comprising perivascular stem cells and nell-1 protein
CN101985052B (zh) * 2010-08-31 2013-11-06 中国人民解放军第二军医大学 自动捕获内皮祖细胞促进血管化的皮肤替代物及其构建方法
US20130236429A1 (en) * 2010-09-23 2013-09-12 Children's Medical Center Corporation Engineered vascular adipose tissue
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2012048093A2 (en) 2010-10-08 2012-04-12 Osiris Therapeutics, Inc. Enhanced msc preparations
US8834928B1 (en) 2011-05-16 2014-09-16 Musculoskeletal Transplant Foundation Tissue-derived tissugenic implants, and methods of fabricating and using same
CN107638428B (zh) * 2011-05-19 2021-07-23 麦瑟布莱斯特公司 用于治疗肥胖症和/或代谢综合征的方法
CN103826646A (zh) * 2011-06-03 2014-05-28 麦瑟布莱斯特公司 治疗中风的影响的方法
EP2714057B1 (en) * 2011-06-03 2019-11-06 Mesoblast, Inc. Methods of treating or preventing neurological diseases
JP6145089B2 (ja) 2011-06-07 2017-06-07 メソブラスト インターナショナル エスエイアールエル ストロマ細胞由来因子−１のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
US9265796B2 (en) 2011-07-04 2016-02-23 Mesoblast, Inc. Methods of treating or preventing rheumatic disease
CN104508124B (zh) 2011-07-06 2017-11-17 细胞治疗有限公司 中胚层谱系祖细胞
EP2734618B1 (en) * 2011-07-20 2017-06-14 Paracelsus Medizinische Privatuniversität Salzburg - Privatstiftung Pluripotent tendon and ligament perivascular cells
AU2012300221A1 (en) * 2011-08-29 2014-04-17 Safeguard Cell Technology Inc. Isolating and therapeutic use of perivascular medicinal cells
JP5831059B2 (ja) * 2011-09-07 2015-12-09 ソニー株式会社 光学的測定装置、フローサイトメーター及び光学的測定方法
US9177336B2 (en) * 2011-09-08 2015-11-03 Telefonaktiebolaget L M Ericsson (Publ) Apparatuses and methods for recommending a path through an information space
EP3351256A1 (en) 2011-09-09 2018-07-25 Mesoblast, Inc. Method for increasing osteoblastic function
CN102539736B (zh) * 2011-12-16 2015-04-29 北京汉氏联合生物技术有限公司 一种cd106阳性细胞、其鉴定、制备方法及应用
CN104684561A (zh) 2012-08-01 2015-06-03 联合治疗公司 利用间充质干细胞的肺动脉高血压的治疗
JP6746313B2 (ja) 2012-08-01 2020-08-26 ユナイテッド セラピューティクス コーポレイション プロスタサイクリン処理された内皮前駆細胞による肺動脈性高血圧症の処置
SG11201504340YA (en) * 2012-12-12 2015-07-30 Mesoblast Inc Treatment of diseases of endothelial dysfunction and inflammation
CA2893951C (en) * 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
KR102466885B1 (ko) 2013-01-09 2022-11-11 유나이티드 세러퓨틱스 코오포레이션 프로스타시클린 및 중간엽 줄기 세포를 사용한 혈관병증의 치료
WO2015017500A1 (en) 2013-07-30 2015-02-05 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
AU2014362198A1 (en) * 2013-12-13 2016-07-07 Mesoblast International Sarl Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
KR102577698B1 (ko) 2014-04-07 2023-09-12 메조블라스트 인터내셔널 에스에이알엘 개선된 줄기 세포 조성물
AU2015243236B2 (en) * 2014-04-11 2020-12-03 The Administrators Of The Tulane Educational Fund Cell-surface marker of early MSC aging
WO2015189063A1 (en) 2014-06-10 2015-12-17 Mesoblast International Sàrl Treatment of immune disorders
CN106661552B (zh) 2014-07-11 2020-07-07 玛土撤拉有限公司 心脏细胞培养材料
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
CA3247653A1 (en) 2014-12-23 2025-10-31 Mesoblast International Sarl Method for treating heart failure
CN107206027A (zh) 2014-12-23 2017-09-26 迈索布拉斯特国际有限公司 进行性心力衰竭的预防
US20180037867A1 (en) 2015-03-04 2018-02-08 Mesoblast International Sàrl Cell culture method for mesenchymal stem cells
AU2016258980B2 (en) 2015-05-05 2022-02-17 Mesoblast International Sàrl Potency assay
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US10912864B2 (en) 2015-07-24 2021-02-09 Musculoskeletal Transplant Foundation Acellular soft tissue-derived matrices and methods for preparing same
US11052175B2 (en) 2015-08-19 2021-07-06 Musculoskeletal Transplant Foundation Cartilage-derived implants and methods of making and using same
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CN111500534B (zh) * 2016-07-11 2022-11-29 山东亚大药业有限公司 分离纯化胎儿有核红细胞的试剂盒
JP7179723B2 (ja) 2016-10-24 2022-11-29 ユナイテッド セラピューティクス コーポレイション トレプロスチニルによるｍｓｃの免疫調節特性の増強
EP3543331A4 (en) 2016-11-15 2020-07-01 Kaneka Corporation CELL POPULATION CONTAINING MESENCHYMAL STEM CELLS DERIVED FROM F RATE APPENDICES, METHOD FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION
WO2018155651A1 (ja) * 2017-02-24 2018-08-30 株式会社メトセラ 線維芽細胞を含む心臓疾患を治療するための注射用組成物、及び治療用線維芽細胞の製造方法
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
EP3619294A1 (en) 2017-05-04 2020-03-11 Mesoblast International Sàrl Mesenchymal lineage precursor or stem cells with enhanced immunosuppression
WO2019102268A1 (en) 2017-11-22 2019-05-31 Mesoblast International Sarl Cellular compositions and methods of treatment i
JP7454379B2 (ja) 2017-12-28 2024-03-22 株式会社カネカ 接着性幹細胞を含む細胞集団とその製造方法、及び医薬組成物
JP7614106B2 (ja) 2018-10-31 2025-01-15 メゾブラスト・インターナショナル・エスアーエールエル 造血幹細胞の拡大
CN109321522A (zh) * 2018-11-20 2019-02-12 潍坊市康华生物技术有限公司 一种制备牙髓干细胞的方法
EP4772245A3 (en) 2019-01-02 2026-08-19 Mesoblast International Sàrl Method for treating lower back pain
US12702683B2 (en) 2019-01-03 2026-08-11 Mesoblast International Sárl Method for improving visual acuity
US20220160776A1 (en) 2019-01-28 2022-05-26 Mesoblast International Sárl Method for treating or preventing gastrointestinal bleeding
CN113853206A (zh) 2019-05-23 2021-12-28 迈索布拉斯特国际有限公司 脑梗塞的功能恢复
WO2020251020A1 (ja) 2019-06-14 2020-12-17 株式会社カネカ 間葉系細胞を含む細胞集団、それを含む医薬組成物、及び、その製造方法
KR20220038485A (ko) 2019-08-05 2022-03-28 메조블라스트 인터내셔널 에스에이알엘 바이러스 벡터를 포함하는 세포 조성물 및 치료 방법
CN115996735A (zh) 2020-08-10 2023-04-21 迈索布拉斯特国际有限公司 细胞组合物和治疗方法
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
EP4536253A1 (en) 2022-06-08 2025-04-16 Mesoblast International Sàrl Mesenchymal progenitor cells for enhancing partial reprogramming of target cells
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
CN115184246B (zh) * 2022-09-14 2023-07-04 天津昂赛细胞基因工程有限公司 一种利用cd155评价间充质干细胞生物学效力的方法
JP2025539861A (ja) * 2022-11-25 2025-12-09 エルピス・セル・セラピューティクス ｖＭＳＣのセクレトームおよびその用途
WO2024121821A1 (en) 2022-12-09 2024-06-13 Mesoblast International Sarl Conditioned media and use of the same
AU2023389700A1 (en) 2022-12-09 2025-07-10 Mesoblast International Sarl Method of treating heart failure in subjects with persistent inflammation
JP2025538783A (ja) 2022-12-09 2025-11-28 メゾブラスト・インターナショナル・エスアーエールエル 事前承認された組成物及び細胞培養方法
WO2025062365A1 (en) 2023-09-22 2025-03-27 Mesoblast International Sárl Mesenchymal lineage precursor or stem cells (mlpscs) for use in methods of treating congenital heart disease

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5226914A (en) 1990-11-16 1993-07-13 Caplan Arnold I Method for treating connective tissue disorders
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5197985A (en) 1990-11-16 1993-03-30 Caplan Arnold I Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
IL107642A0 (en) 1992-11-20 1994-02-27 Amgen Inc Progenitor b cell stimulating factor
US5405772A (en) 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5591625A (en) 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US5405722A (en) * 1993-12-22 1995-04-11 Rca Thomson Licensing Corp. Method for combined baking-out and sealing of an electrophotographically processed screen assembly for a cathode-ray tube
US5792453A (en) 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
WO1997018298A1 (en) 1995-11-14 1997-05-22 Regents Of The University Of Minnesota Ex vivo culture of stem cells
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
US6335195B1 (en) 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
CA2294944A1 (en) 1997-07-03 1999-01-14 Osiris Therapeutics, Inc. Human mesenchymal stem cells from peripheral blood
WO1999003973A1 (en) 1997-07-14 1999-01-28 Osiris Therapeutics, Inc. Cardiac muscle regeneration using mesenchymal stem cells
WO1999011287A1 (en) 1997-09-04 1999-03-11 Osiris Therapeutics, Inc. Ligands that modulate differentiation of mesenchymal stem cells
US6368636B1 (en) 1998-03-18 2002-04-09 Osiris Therapeutics, Inc. Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
WO1999061587A1 (en) 1998-05-29 1999-12-02 Osiris Therapeutics, Inc. Human cd45+ and/or fibroblast + mesenchymal stem cells
ATE382681T1 (de) * 1998-07-31 2008-01-15 Genzyme Corp Verbesserung der herzfunktion durch transplantation mesenchymaler stammzellen
RU2306335C2 (ru) * 1999-03-10 2007-09-20 Юниверсити Оф Питтсбург Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн Стволовые клетки и решетки, полученные из жировой ткани
US7670628B2 (en) 1999-07-07 2010-03-02 Angioblast Systems, Inc. Mesenchymal precursor cell
US8062675B2 (en) 1999-07-07 2011-11-22 Angioblast Systems, Inc. Mesenchymal precursor cell
US20050158289A1 (en) 1999-07-07 2005-07-21 Simmons Paul J. Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
AUPQ147799A0 (en) 1999-07-07 1999-07-29 Medvet Science Pty. Ltd. Mesenchymal precursor cell
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
WO2001007679A1 (en) 1999-07-26 2001-02-01 Chemetall Plc Metal surface treatment
EP1226233B1 (en) 1999-08-05 2011-06-29 ABT Holding Company Multipotent adult stem cells and methods for isolation
CA2346362C (en) 2000-05-26 2010-06-15 Stemcell Technologies Inc. Novel antibody compositions for preparing enriched mesenchymal progenitor preparations
AU7707801A (en) * 2000-07-21 2002-02-05 Us Health Adult human dental pulp stem cells in vitro and in vivo
CA2438501C (en) 2001-02-14 2014-09-16 Leo T. Furcht Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
FR2827868A1 (fr) 2001-07-30 2003-01-31 Bp Chem Int Ltd Procede et dispositif de fabrication en continu d'un polymere d'alcoylene aromatique
AUPR703601A0 (en) 2001-08-15 2001-09-06 Peter Maccallum Cancer Institute, The Identification and isolation of somatic stem cells and uses thereof
JP2003052365A (ja) * 2001-08-20 2003-02-25 Japan Science & Technology Corp 哺乳動物からの間葉系幹細胞の分離及びその利用方法
US20050271639A1 (en) 2002-08-22 2005-12-08 Penn Marc S Genetically engineered cells for therapeutic applications
JP4061487B2 (ja) * 2002-11-21 2008-03-19 始 大串 血管新生を目的とする移植材料及びその製造方法
US7470538B2 (en) 2002-12-05 2008-12-30 Case Western Reserve University Cell-based therapies for ischemia
WO2004094588A2 (en) * 2003-04-19 2004-11-04 Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health Postnatal stem cells and uses thereof
TR201900968T4 (tr) 2004-09-24 2019-02-21 Mesoblast Inc Multipotansiyel genleşmiş mezenkimal prekürsör hücre soyu (memp) ve bunların kullanımı.
CN101103101B (zh) 2004-09-24 2012-10-10 成血管细胞系统公司 增强间充质前体细胞（mpc）的增生和/或存活的方法
GB0812683D0 (en) * 2008-07-11 2008-08-20 Chalabi Rifat A Multi-heat zone gasifier
US7942266B2 (en) * 2009-04-01 2011-05-17 Lincoln Global, Inc. Electrode packaging to reduce handling damage

Similar Documents

Publication Publication Date Title
Klimczak et al. Mesenchymal stromal cells and tissue‐specific progenitor cells: Their role in tissue homeostasis
Shiota et al. Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties
JP6257559B2 (ja) 脈管周囲の間葉系前駆細胞
Gojo et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells
Wang et al. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications
Kocher et al. Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
Yamada et al. Cardiac progenitor cells in brown adipose tissue repaired damaged myocardium
Kudo et al. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart
Brunt et al. Endothelial progenitor cell and mesenchymal stem cell isolation, characterization, viral transduction
Govindasamy et al. Micromanipulation of culture niche permits long-term expansion of dental pulp stem cells—an economic and commercial angle
Khan et al. Combination of mesenchymal stem cells and three-dimensional collagen scaffold preserves ventricular remodeling in rat myocardial infarction model
Itescu et al. Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function
AU2017200149A1 (en) Perivascular mesenchymal precursor cells
Kapsa et al. CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci
Itescu et al. Adult bone marrow-derived angioblasts for improvement of cardiomyocyte function after myocardial ischemia
Blastocysts Perspectives: Plasticity of Stem Cells
Baustian Prospective isolation and characterisation of mouse bone marrow-derived mesenchymal stromal cells